multiple sclerosis (ms)

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Quality of Life of Multiple Sclerosis Patients Treated With

Not yet recruiting
  • Multiple Sclerosis (MS)
  • ofatumumab
  • (no location specified)
Nov 27, 2023

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

Recruiting
  • Multiple Sclerosis (MS)
  • Physical activity behavioral intervention in persons newly diagnosed with MS
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2023

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multimodal Imaging Signatures of Biological Mechanisms

Not yet recruiting
  • Multiple Sclerosis (MS)
  • MRI
  • (no location specified)
Jan 12, 2023

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Little Rock, Arkansas
  • +55 more
Jan 13, 2023

Multiple Sclerosis (MS) Trial in Basel, Luzern 16, Rheinfelden (Neurostatus-SMARTCARE, Standard Neurostatus-EDSS)

Recruiting
  • Multiple Sclerosis (MS)
  • Neurostatus-SMARTCARE
  • Standard Neurostatus-EDSS
  • Basel, Switzerland
  • +2 more
Jan 2, 2023

Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)

Recruiting
  • Multiple Sclerosis (MS)
  • Relapsing Remitting Multiple Sclerosis
  • Cullman, Alabama
  • +14 more
Dec 13, 2022

MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study

Completed
  • Multiple Sclerosis (MS)
    • Baltimore, Maryland
    • +5 more
    Sep 14, 2022

    Multiple Sclerosis (MS) Trial in Ann Arbor, London (11C-BMS-986196)

    Recruiting
    • Multiple Sclerosis (MS)
    • Ann Arbor, Michigan
    • +1 more
    May 26, 2022

    Multiple Sclerosis (MS) Trial in Basel (SC MRI, patient questionnaire)

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • SC MRI
    • patient questionnaire
    • Basel, Switzerland
      University Hospital Basel, Department of Neurology
    May 17, 2022

    Benefit of Natalizumab At-home Infusion vs At-hospital Infusion

    Recruiting
    • Multiple Sclerosis (MS)
    • At-home natalizumab treated MS patient
    • Strasbourg, Bas-Rhin, France
    • +19 more
    Mar 22, 2022

    Multiple Sclerosis (MS) Trial in Toronto (Metformin, Placebo)

    Recruiting
    • Multiple Sclerosis (MS)
    • Toronto, Ontario, Canada
    • +1 more
    Mar 15, 2022

    Multiple Sclerosis (MS) Trial in Dallas (Alemtuzumab)

    Completed
    • Multiple Sclerosis (MS)
    • Dallas, Texas
    • +1 more
    Jan 24, 2022

    Multiple Sclerosis (MS) Trial in Worldwide (Nabiximols, Placebo)

    Recruiting
    • Multiple Sclerosis (MS)
    • Port Charlotte, Florida
    • +27 more
    Jan 27, 2022

    Patterns Between Digital Outcome Assessments From Konectom™

    Recruiting
    • Multiple Sclerosis (MS)
    • Konectom platform
    • Dresden, Germany
      Research Site
    Jan 7, 2022

    Severe Acute Respiratory Syndrome Coronavirus Type 2-Related

    Recruiting
    • Multiple Sclerosis (MS)
      • Bamberg, Germany
      • +11 more
      Jan 17, 2022

      Imaging Interplay Between Axonal Damage and Repair in Multiple

      Recruiting
      • Multiple Sclerosis (MS)
      • +3 more
      • MRI
      • +2 more
      • Basel, Switzerland
        University Hospital Basel, Department of Neurology
      Dec 15, 2021

      Multiple Sclerosis (MS) Trial in Canada, United States (elezanumab, )

      Completed
      • Multiple Sclerosis (MS)
      • Phoenix, Arizona
      • +36 more
      Dec 15, 2021

      Multiple Sclerosis (MS) Trial in Canada, United States (elezanumab, )

      Completed
      • Multiple Sclerosis (MS)
      • Birmingham, Alabama
      • +48 more
      Dec 1, 2021

      Pregnancy Cohort in Multiple Sclerosis (MS)

      Recruiting
      • Multiple Sclerosis (MS)
      • Clinically Isolated Syndrome (CIS)
        • Berlin, Germany
          Charité Universitätsmedizin Berlin
        Aug 17, 2021

        Multiple Sclerosis (MS), Multiple Sclerosis (MS) Relapsing Remitting, Multiple Sclerosis (MS) Primary Progressive Trial in

        Completed
        • Multiple Sclerosis (MS)
        • +6 more
        • Video-oculography / Social cognition tasks / Neuropsychological evaluations
        • Monaco, Monaco
          Centre Mémoire / Centre de Gérontologie Clinique Rainier III / P
        Jan 19, 2021

        Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Odense (Intake of red and processed meat and fibres, Lifestyle factors

        Active, not recruiting
        • Autoimmune Diseases
        • +8 more
        • Intake of red and processed meat and fibres
        • Lifestyle factors independently or combined
        • Odense, Denmark
          University of Southern Denmark
        Nov 6, 2020

        MSRV-Env Burden in Patients With Multiple Sclerosis Disease

        Completed
        • Multiple Sclerosis (MS)
        • +4 more
        • No study treatments administered - blood draws only
        • Bron cedex, France
        • +3 more
        Oct 19, 2020

        Emotional Processing in Multiple Sclerosis / Clinically Isolated

        Completed
        • Multiple Sclerosis (MS)
        • Clinically Isolated Syndrome (CIS)
          • Berlin, Germany
            Charité Unversitätsmedizin Berlin; NeuroCure Clinical Research C
          Jul 15, 2020